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Abstract 
Splicing, the removal of non-protein-coding introns from pre-mRNA, is a critical 
step in eukaryotic gene expression. Splicing is catalyzed by the spliceosome, which is 
composed of five small nuclear RNAs (Ul, U2, U4, U5, and U6) and over 100 proteins. 
To facilitate molecular dissection of the structure and function of U4, we have developed 
an in vitro assay for reconstitution of functional U4 snRNPs. Depletion of U4 strongly 
inhibited splicing, and subsequent addition of wild-type in vitro transcribed U4 allowed 
efficient recovery of splicing. Analysis of reconstitution by U4 3' truncation mutants 
showed that, while the Sm protein binding site was dispensable for splicing in vitro, 
shorter mutants lacking the 3' stem-loop were unable to reconstitute splicing. We showed 
that the 3' stem-loop was essential for formation of the yeast di-snRNP, but it was 
dispensable for subsequent steps of spliceosome assembly and splicing. 
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CHAPTER 1 
Introduction 
1.1 Gene Expression 
Proteins play an incredibly diverse range of structural and functional roles in the 
physiology of all living organisms. These include acting as the enzymes that catalyze nearly 
all chemical reactions that occur in a cell; acting as hormones involved in communication 
between cells; and functioning as integral parts of the immune system. Given this extensive 
array of functions, it is clear that expression of any given protein may only be required in 
certain cell types or at certain times of development. It is also energetically expensive to 
produce proteins. Consequently, proteins are only produced when and where they are 
required. 
The instructions for producing proteins are encoded in genes in the DNA, which in 
eukaryotic organisms is found within the nucleus. When the protein product of a specific 
gene is required, an RNA copy of the gene, called precursor messenger RNA (pre-mRNA), is 
generated through transcription. This gene copy undergoes a number of processing events, 
including 5' cap formation and addition of a polyadenosine tail, before it is exported to the 
cytoplasm where it directs protein synthesis through interaction with the ribosome during 
translation. 
1.2 Pre-mRNA Splicing 
A feature of nearly all eukaryotic genes is that they are interrupted by sequences that 
do not code for protein. These intervening sequences, or introns, are included in the RNA 
copy of the gene and therefore must be removed from the pre-mRNA before it can be used to 
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direct protein synthesis. The process of removing introns from the pre-mRNA and 
reconnecting the flanking coding sequences, or exons, to form mature mRNA is known as 
pre-mRNA splicing. Although it has been more than 30 years since the discovery of introns 
within the coding sequences of genes (Berget et al. 1977, Chow et al. 1977), scientists are 
still far from fully understanding the splicing process due to its complexity. 
Splicing is guided by three conserved regions of the pre-mRNA transcript: the 5' and 
3' splice sites (ss), which mark the intron boundaries, and the branch point sequence, which is 
found upstream of the 3'ss and contains an important adenosine residue (Figure 1). The 5' 
and 3' boundaries of an intron are defined by a GU and an AG dinucleotide, respectively, 
more than 99% of the time (Burset et al. 2000, Black 2003). The small number of remaining 
introns are defined by non-canonical sequences (Burset et al. 2000). These elements of the 
pre-mRNA are central to the two transesterification reactions by which splicing is 
accomplished. 
In the first step of splicing, the phosphate at the 5' splice site undergoes nucleophilic 
attack by the free 2' hydroxyl of the branch point adenosine, freeing the 5' exon. The 3' exon 
remains attached to the intron, which assumes a lariat configuration due to formation of a 2' -
to-5' phosphodiester bond between the branch point adenosine and the 5' end of the intron. In 
the second reaction, nucleophilic attack of the 3' splice site by the 3' hydroxyl of the 5' exon 
joins the two exons, producing mature mRNA and releasing the intron lariat (Figure 1). 
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Figure 1. The two chemical reactions of pre-mRNA splicing. The intron is represented by 
a black line and the branch point adenosine by AQH-
The process of splicing is made more complex by the presence of multiple introns in 
a single pre-mRNA transcript. Such transcripts require multiple splicing events for formation 
of mature mRNA, and, through alternative splicing, allow for production of numerous 
protein isoforms from a singe gene (reviewed in Black 2003). Alternative splicing is a major 
contributor to the protein diversity of higher eukaryotes. In humans, for example, it is 
estimated that alternative splicing plays a role in expression of over 70% of genes (Johnson 
et al. 2003). Thus, the approximately 22,000 genes of the human genome to encode an 
estimated 90,000 proteins, helping to explain the complexity of humans relative to much 
simpler organisms possessing a comparable number of genes (Harrison 2002). 
1.3 Splicing and Disease 
Given the central role of splicing in gene expression and the single-nucleotide 
accuracy of splice site recognition required to produce the correct protein, it is not surprising 
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that many diseases stem from errors in splicing. In fact, it has been estimated that 
approximately half of all human genetic diseases are the result of mutations which affect 
splicing (Buratti et al. 2006, Lopez-Bigas et al. 2005). These include spinal muscular 
atrophy, which is one of the most common causes of childhood mortality; a group of eye 
conditions known as retinitis pigmentosa, which ultimately result in blindness; and 
neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Mutations in 
splicing have also been linked to cystic fibrosis, myotonic dystrophy, and a large number of 
cancers (Faustino and Cooper 2003). The ultimate discovery of cures for such diseases is 
closely tied to determining their molecular origins. 
1.4 Yeast as a Model Organism 
Although the ultimate goal of pre-mRNA splicing studies is to elucidate the 
mechanism by which this fundamental process occurs in our own bodies, many of these 
studies are carried out in yeast (Saccharomyces cerevisiae). There are a number of reasons 
why yeast is an attractive model organism for biochemical studies, and for splicing studies in 
particular. First, yeast has been the subject of intense genetic analysis for over a century, 
resulting in the availability of a vast array of genetic tools and mutant strains (Miesfeld 
1999). Furthermore, many biochemical tools and techniques are available for yeast, including 
a well-established protocol for in vitro splicing that has proved invaluable to investigations of 
the effects of genetic modifications on splicing (Lin et al. 1985). Second, yeast is a 
eukaryotic system which is considerably less complex than other eukaryotic systems, such as 
the mammalian cell. The yeast genome, at twelve million DNA base-pairs, is 250 times 
smaller than the three billion-base-pair human genome. The relative simplicity of the yeast 
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genome allowed for its complete sequencing by 1996 (Goffeau et al. 1996), which had an 
enormous impact on yeast research. Genomic sequencing has revealed that, of the 
approximately 6000 genes found in yeast (Goffeau et al. 1996), only about 250 of them, or 
less than 5%, contain an intron (Davis et al. 2000). In comparison, over 95% of human genes 
contain an intron (Lander et al. 2001). Study of splicing in yeast is further enhanced by the 
fact that the vast majority of intron-containing genes in yeast possess only a single intron 
(SGD Project 1997), eliminating interference from alternative splicing. Finally, a large 
number of genes are evolutionarily conserved between yeast and humans (Miesfeld 1999). 
For example, among splicing-related molecules, the protein Prp8 is 62% identical between 
yeast and humans (Luo et al. 1999) and the catalytically important central domain of U6 
RNA is 80% identical (Guthrie and Patterson 1988, Brow and Guthrie 1989). The high 
degree of conservation of splicing components and mechanism between these organisms 
means that details of the splicing process obtained from yeast research are highly relevant to 
our understanding of this process in humans (Rymond and Rosbash 1992). 
1.5 The Spliceosome and the Splicing Cycle 
The average human gene contains eight exons, each approximately 145 nucleotides in 
length (Lander et al. 2001). These coding sequences are distinguished from the surrounding 
introns, which average more than ten times the length of an exon (Lander et al. 2001), by 
relatively short, degenerate 5' and 3' ss sequences. The task of recognizing these genetic 
signals and thereby discriminating between exon and intron belongs to a dynamic 
macromolecular complex called the spliceosome. 
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The spliceosome is an enzymatic ribonucleoprotein complex containing five different 
small nuclear RNAs (snRNAs) that are particularly rich in uridine residues and are thus 
known as Ul, U2, U4, U5, and U6. Each of these RNAs interacts with a number of proteins 
to form the associated small nuclear ribonucleoprotein particle (snRNP). Through a highly 
orchestrated series of interactions with each other and the pre-mRNA, these snRNPs modify 
the original gene transcript en route to its becoming mature mRNA ready to undergo 
translation. 
The primary interaction between the splicing machinery and the pre-mRNA occurs 
between the Ul snRNP and the 5' ss (Figure 2), forming the E complex or commitment 
complex. Subsequently, the U2 snRNP forms a base-pairing interaction with the branch 
point, assisted by an assembly of branch point-binding proteins, forming the B complex or 
pre-spliceosome. This is followed by participation of the U4/U6»U5 tri-snRNP, which 
consists of extensively base-paired U4 and U6 snRNPs in association with the U5 snRNP, 
forming the A complex (reviewed in Nilsen 1994, Staley and Guthrie 1998). 
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Figure 2. The cycle of snRNP assembly complexes involved in pre-mRNA splicing. The 
red arrow indicates the overall result of intron removal. 
The interactions of these five snRNPs with each other and the pre-mRNA substrate 
are highly dynamic. Following entrance of the tri-snRNP, a number of rearrangements occur 
within the A complex that cause it to become catalytically active. These rearrangements are 
assisted by a family of ATP-dependent RNA unwindases known as the DEAD/DEXH-box 
proteins (Staley and Guthrie 1998). Binding of Ul at the 5' ss is replaced by U6, and base-
pairing between U4 and U6 is disrupted to allow formation of mutually exclusive structures 
involving an interaction between U2 and U6 (Madhani and Guthrie 1992) and a U6 
intramolecular stem-loop that coordinates a metal ion important for 5' ss cleavage (Yean et 
al. 2000, Huppler et al. 2002). The result of these exchanges is the destabilization or release 
of Ul and U4 from the spliceosome, leaving U2 and U6 bound to the branch point and 5' ss, 
respectively, with U5 interacting with the two exons. This arrangement of U2, U5, and U6 
assembled on the pre-mRNA is termed the active spliceosome (Figure 2), and it is this set of 
components that actually catalyzes the two chemical steps of splicing. Once the splicing 
reaction is complete, the excised intron is degraded and the snRNPs are returned to their 
original conformations to be recycled through future rounds of splicing (Staley and Guthrie 
1998). 
1.6 The Role of the U4 snRNP in Splicing 
1.6.1 Current Understanding 
While the general roles of Ul, U2, U5, and U6 in the splicing process are at least 
reasonably well understood, the function of U4, though essential for splicing (Berget and 
Robberson 1986, Black and Steitz 1986, Siliciano et al. 1987, Brow and Guthrie 1988), is 
not. Like Ul, U4 is not directly involved in catalysis of splicing, as it is thought to exit the 
spliceosome prior to the first chemical reaction (Pikielny et al. 1986, Cheng and Abelson 
1987, Lamond et al. 1988, Yean and Lin 1991). However, unlike Ul, U4 is not known to 
form any contacts with the pre-mRNA, although cross-linking studies have demonstrated that 
U4 is in close proximity to the 5' ss at early stages of spliceosome assembly (Johnson and 
Abelson 2001). 
It is known that U4 forms an extensive and stable base-pairing interaction with U6 
through intermolecular stems I and II (Figure 3a; Brow and Guthrie 1988, Guthrie and 
Patterson 1988). Formation of the U4/U6 base-pairing interaction is catalyzed by the splicing 
factor Prp24 (Ghetti et al. 1995, Raghunathan and Guthrie 1998). The mechanism for 
formation of this duplex is not known, though it has been suggested to occur through a so-
called kissing-loop interaction (Figure 3b) (Karaduman et al. 2006; Ollenberger and Rader, 
unpublished results). Furthermore, the function of this U4/U6 interaction has yet to be 
established. 
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Figure 3. Secondary structures of the U4 (yellow) and U6 (red) snRNAs. a) The U4/U6 
di-snRNA containing intermolecular stems I and II. b) Potential mechanism of 
initiation of base-pairing between free U4 and U6 snRNAs. 
One hypothesis is that the U4/U6 interaction allows U4 to function as a negative 
regulator of U6 activity. Prior to the first catalytic step of the splicing reaction, U6 must 
undergo a remarkable series of rearrangements in which base-pairing between U4 and U6 is 
broken to allow U6 to form mutually exclusive interactions with U2 and the 5' ss (Figure 4, 
Umen and Guthrie 1995). It has therefore been proposed that U4 may prevent premature 
rearrangements of U6 by holding it in an inactive conformation through sequestration of its 
catalytic residues (Guthrie and Patterson 1988, Brow and Guthrie 1989). Disruption of the 
U4/U6 interaction and release of U4 from the spliceosome would then act as a switch for 
spliceosome activation, and factors that stabilize or destabilize the U4/U6 interaction would 
regulate this activation (Murray and Jarrell 1999). However, given that yeast cells contain a 
large molar excess of U6 over U4 (Li and Brow 1993), and that these molecules are thought 
to interact in a one-to-one manner (Hashimoto and Steitz 1984, Rinke et al. 1985, Brow and 
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Guthrie 1988, Bindereif et al. 1990), it is not plausible that U4 acts as a negative regulator of 
a molecule so much more abundant than itself. 
A second hypothesis is that U4 instead acts as an activator of splicing. It is clear that 
interaction between U4 and U6 is required for incorporation of the latter into the spliceosome 
(Brow and Guthrie 1988, Staley and Guthrie 1998). This observation has led to the 
suggestion that U4 may activate U6 by holding it in a favorable conformation for interaction 
with the pre-mRNA (McConnell and Steitz 2001). Although the mechanistic explanation for 
this activation is unknown, it is an attractive proposal since it is more consistent with the 
relative levels of U4 and U6 found in yeast cells (Li and Brow 1993). In fact, these two 
hypotheses regarding the function of U4 may not be mutually exclusive; U4 may initially act 
as an activator to allow U6 to enter the spliceosome, where it may then adopt a negative 
regulatory role, preventing the conformational changes required for progression to the active 
spliceosome until the correct base-pairing between U6 and the 5' ss has been established. 
1.6.2 Structural Basis for a Role of U4 in Spliceosome Activation 
As the function of each snRNP is intimately linked to its structure, elucidation of 
these structures provides important insights into the splicing mechanism. Although an 
activating role for U4 in spliceosome assembly seems reasonable, evaluation of this 
possibility has been hindered by lack of a structural model of free U6 prior to its interaction 
with U4 that could explain such an activating effect. While a number of structural models of 
free U6 have been proposed (Fortner et al. 1994, Ryan et al. 2002, Karaduman et al. 2006), 
none are entirely consistent with existing structure probing data or the known interactions of 
U6. However, the Rader Lab has recently proposed a new model for the structure of free U6 
10 
that addresses a significant number of the shortcomings of existing models (Dunn and Rader, 
unpublished). A key feature of this model is the prediction of a molecular mechanism by 
which the U4/U6 interaction could allow U6 to enter the spliceosome (Figure 4), something 
that previous models did not incorporate. Specifically, in contrast to previous U6 models, a 
catalytically important region of U6, the ACAGAGA sequence, is suggested to be 
sequestered in the Dunn-Rader model (Figure 4), preventing premature interaction with the 
pre-mRNA. Formation of the U4/U6 di-snRNP frees this sequence, thus activating U6 for 
participation in spliceosome assembly and splicing (Figure 4). 
Free snRNP Di-snRNP Catalylicolly Active 
Spliceosome 
Figure 4. Model for activation of U6 through interaction with U4. The catalytically 
important ACAGAGA sequence of U6 (red), sequestered in the free snRNP (left), is 
exposed through formation of the U4/U6 di-snRNP (middle), allowing subsequent 
interaction with the 5' splice site of the pre-mRNA (right). 
Further examination of the role of U4 in splicing is necessary to determine whether 
U4 does in fact function as an activator of U6. One approach to examine such a role in 
activation is to identify the minimum U4 sequence required for di-snRNP formation and 
subsequent interaction of U6 with the pre-mRNA, and to determine whether this sequence is 
consistent with the U6-activating sequence, U4 stem II, predicted by the Dunn-Rader model 
of U6. These studies would benefit significantly from availability of a yeast system enabling 
in vitro reconstitution of functional U4 snRNPs. 
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1.7 In Vitro Splicing Reconstitution 
In vitro reconstitution assays are powerful tools for molecular dissection of biological 
processes. Splicing reconstitution assays are particularly useful for identifying essential 
constituents of the reaction and can provide important insights into the interactions, structure, 
and function of molecules involved in splicing. These assays involve depletion of a specific 
component of the splicing machinery from cell extract to abolish splicing activity, followed 
by complementation with a modified version of that component to allow examination of the 
effects of certain mutations on splicing activity or to investigate the interactions formed by 
that component (Newman 1994). 
A number of early studies demonstrating in vitro reconstitution of all five mammalian 
snRNPs have identified snRNA domains required for snRNP assembly (Hamm et al. 1987, 
1989, Patton et al 1987, Riedel et al. 1987, Patton and Perderson 1988, Kleinschmidt et al. 
1989, Pikielny et al. 1989, Bindereif et al. 1990, Wersig and Bindereif 1990, Sumpter et al. 
1992). Importantly, these in vifro-assembled snRNPs have been shown to be active in 
splicing (Wersig and Bindereif 1992, Wolff and Bindereif 1992, Segault et al. 1995, Will et 
al. 1996). Similar in vitro splicing reconstitution systems have been developed for yeast U2, 
U5, and U6 (Fabrizio et al. 1989, McPheeters et al. 1989, O'Keefe et al. 1996), although 
there has been no report of reconstitution analyses of yeast Ul or U4. Together, these 
splicing reconstitution assays have facilitated numerous analyses of snRNP function and 
have allowed elucidation of snRNA functional domains and their protein interaction partners 
(Fabrizio and Abelson 1990, Wolff et al. 1994, Dix et al. 1998, O'Keefe and Newman 1998, 
Vidal et al. 1999, Alvi et al. 2001, McGrail et al. 2006). 
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Considering specifically the human U4 snRNA, in vitro reconstitution with a variety 
of deletion mutants has enabled dissection of the functional domains of this molecule and has 
revealed the roles of these regions in snRNP and spliceosome assembly and splicing activity 
(Wersig and Bindereif 1990, 1992). These studies have shown that, while the 5' portion of 
U4 is necessary for U4/U6 interaction, spliceosome assembly, and splicing, the 3' portion of 
the molecule appears nonessential (Wersig and Bindereif 1990, 1992). Within the 5' region, 
only stem II was found to be essential for splicing, though deletion of either stem I or the 
intervening 5' stem-loop also resulted in a significant reduction of splicing activity (Wersig 
and Bindereif 1992). Similarly, stem II was found to be essential for U4/U6 interaction, 
while a stem I deletion mutant exhibited significantly reduced binding to U6 (Wersig and 
Bindereif 1990). 
While these in vitro reconstitution analyses have provided important insights into the 
domain structure of U4, many questions remain regarding the identity of the functionally 
important nucleotides within these domains, as well as the specific points in the splicing 
cycle at which they act. Furthermore, we have only a limited knowledge of the identities of 
the proteins associated with U4 snRNA, the sequences with which they interact, and the roles 
they may perform during snRNP and spliceosome assembly and splicing catalysis. Given the 
vast array of biochemical and genetic tools and techniques offered by yeast, investigation of 
these questions would be greatly facilitated by the availability of a system for reconstitution 
of functional U4 snRNPs in this organism. 
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1.8 Overall Research Objective 
Despite being an essential component of the pre-mRNA splicing reaction, yeast U4 
snRNA remains largely uncharacterized with respect to its domain structure, the proteins 
with which is associates, and its function. A valuable tool to address these questions would 
be an assay for in vitro reconstitution of functional U4 snRNPs, such as has been highly 
useful in structural and functional analyses of other snRNAs. Accordingly, the aim of the 
research project presented here was to develop a yeast U4 in vitro reconstitution system that 
could then be used to investigate the minimum U4 sequence required for snRNP formation, 
spliceosome assembly, and splicing; whether this sequence is consistent with the predictions 
of the Dunn-Rader model for the structure of free U6; and finally, whether formation of the 
U4/U6 duplex is initiated through a kissing-loop interaction. 
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CHAPTER 2 
Identification of Optimal Conditions for U4 Degradation and Splicing 
Inhibition 
Development of an in vitro assay for reconstitution of functional U4 snRNPs requires 
removal of endogenous U4 from the extract, blocking splicing activity. The extract can then 
be used to examine the activities of mutant versions of U4. To deplete endogenous U4 from 
yeast splicing extract, I used oligonucleotide-directed degradation by RNase H. I considered 
several factors in the design of the RNase H degradation reaction, including concentrations of 
DNA oligonucleotide, enzyme, and ATP, incubation time, and reaction temperature. The 
limits of these parameters are defined, to some extent, by downstream functional studies of 
the depleted extract, namely snRNP and spliceosome assembly, and ultimately, splicing 
activity. Therefore, I examined a range of conditions to balance degradation efficiency with 
maintenance of splicing extract activity. I identified conditions that allowed efficient 
depletion of full-length U4 from yeast extract, effectively blocking spliceosome assembly 
and splicing. 
2.1 Materials and Methods 
2.1.1 Splicing Extract Preparation 
Whole-cell extract was prepared from protease-deficient yeast strain BJ2168 as 
previously described (Ansari and Schwer 1995). Frozen cell pellets were homogenized to a 
very fine powder using a mortar and pestle. 
2.1.2 Oligonucleotide-Directed RNase H Degradation of U4 
RNase H degradation reactions contained 60mM KP04, 2.5mM MgCl2, 3% PEG 
8000, 50% splicing extract, 2mM ATP (unless otherwise stated), 2 units RNase H (unless 
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otherwise stated) (Ambion), the indicated concentrations or amounts of targeting 
oligonucleotide and unlabeled IVT actin pre-mRNA, and dH20 to 8uL. DNA targeting 
oligonucleotides used were 
JPS151 (complementary to U4 nucleotides 1 to 19) 
5' ATTTCCCGTGCATAAGGAT 3' 
SDR553 (complementary to U4 nucleotides 1 to 30) 
5' CTGATATGCGTATTTCCCGTGCATAAGGAT 3' 
Reactions were incubated for 30 minutes (unless otherwise indicated) at 23, 30, or 37°C, as 
indicated in the figures. 
2.1.3 Northern Blot Analysis of U4 Degradation 
I added 200uL stop solution (0.3M NaOAc, ImM EDTA, 0.1% SDS, 34ug/mL E. 
coli tRNA) to each 8uL RNase H reaction, followed by 200uL low-pH 
phenol:cholorform:isoamyl alcohol (25:24:1). Reactions were mixed by inversion, incubated 
at 65°C for five minutes, and spun at 13.2 krpm for five minutes. 170|aL of the aqueous layer 
was removed to a new eppendorf tube, mixed by inversion with 200uL chloroform, and spun 
at 13.2 rpm for one minute. 150uL of the aqueous layer was removed to a new eppendorf 
tube and mixed by inversion with 40ug glycogen and 800uL cold 100% ethanol. Tubes were 
spun at 13.2 krpm for 30 minutes to precipitate the RNA. Pellets were washed with 70uL 
cold 70% ethanol and resuspended in 8uL 7M urea loading buffer. Samples were 
electrophoresed through a 6% 7M urea denaturing polyacrylamide gel at 400V for 30 
16 
minutes. RNA was transferred to a membrane by electroblotting at 450mA for 15 minutes 
followed by UV cross-linking. The membrane was then probed using 32P-labeled U4 14B 
oligonucleotide complementary to the 3' end of U4 and exposed to a phosphor screen. 
To calculate degradation efficiency, autoradiograms were visualized and quantified 
using a Cyclone© phosphoimager and Optiquant© software (Packard Instruments). U4 
degradation efficiency was calculated by dividing the intensity of the full-length U4 band of 
each degradation reaction by the intensity of the same band in the mock degradation reaction 
(lacking targeting oligonucleotide) and subtracting this value from one. 
2.1.4 Pre-mRNA Splicing Assay 
To assess the effect of U4 degradation on splicing activity, I added luL P-labeled 
actin pre-mRNA (4 fmol) to the extract subsequent to the RNase H reaction and incubated 
the reaction at 23°C for 30 minutes. Splicing controls contained 60mM KPO4, 2.5mM 
MgCl2, 3% PEG 8000, 2mM ATP, and 50% splicing extract in 8uL. Following addition of 
luL P-labeled actin pre-mRNA (4 fmol), control reactions were incubated at 23°C for 30 
minutes (positive control) or zero minutes (negative control). Splicing reactions were 
terminated by addition of 200uL stop solution, extracted with phenokchloroform, and 
ethanol precipitated as described in section 2.1.3. Samples were electrophoresed through a 
6% 7M urea denaturing polyacrylamide gel at 400V for one hour. The gel was then exposed 
to a phosphor screen at -80°C. 
To calculate splicing efficiency, autoradiograms were visualized and quantified using 
a Cyclone© phosphoimager and Optiquant© software (Packard Instruments). Percent 
splicing was calculated by dividing the intensity of bands corresponding to product (mRNA 
and lariat) by the total intensity of all bands (pre-mRNA, lariat-3' exon, 5' exon, lariat, and 
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mRNA). Splicing inhibition was calculated by dividing the percent splicing of the depleted 
extract by that of the mock-depleted extract and subtracting this value from 1. 
2.1.5 Spliceosome Assembly Gels 
To assess the effect of U4 degradation on spliceosome assembly, 8uL aliquots of 
mock- or U4-depleted splicing extract were incubated with luL 32P-labeled actin pre-mRNA 
(4 fmol) at 23°C for the indicated time before being adjusted to 0.7mg/mL heparin and 12% 
glycerol and run on a 1.5% agarose gel in 50mM tris/glycine buffer for 3.5 hours at 70V. The 
gel was dried and exposed to a phosphor screen for visualization. 
2.2 Results and Discussion 
2.2.1 Optimal Conditions for U4 Degradation 
There has been a previous attempt to develop a yeast in vitro splicing reconstitution 
assay through RNase H degradation of U4, but it was not successful (Fabrizio and Abelson, 
unpublished results; Horowitz and Abelson 1993). In that study, a DNA oligonucleotide that 
targeted U4 nucleotides 72 to 92 was used, as it had been shown to direct nearly complete 
degradation of the target sequence (Xu et al. 1990). However, Fabrizio and Abelson 
(unpublished results) found that degradation of this central region of U4 failed to block 
splicing activity. 
I, instead, targeted the 5' end of U4, which has been shown to be essential for U4/U6 
assembly and splicing (Vankan et al. 1990, 1992; Wersig and Bindereif 1990, 1992). 
Although Xu et al. (1990) found this region of yeast U4 to be almost entirely resistant to 
oligonucleotide-directed RNase H degradation, I found that it can be efficiently degraded by 
RNase H in reactions performed under conditions of active pre-mRNA splicing in which 
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snRNPs are being recycled for future rounds of splicing (Figure 5, lanes 4-7; Figure 8, lanes 
5-8). The explanation for this observed increase in degradation of the 5' end of U4 under 
splicing conditions is that, during spliceosome assembly, the U4 snRNP that entered the 
spliceosome base-paired to U6 is thought to be ejected from this complex as a free particle. 
In this free U4 species, the 5' region that is normally engaged in base-pairing with U6 is 
believed to adopt a stem-loop conformation that is more accessible to the targeting DNA 
oligonucleotide (Figure 3). Titration of actin pre-mRNA showed that higher amounts of 
actin, and thus higher levels of splicing activity, allowed increased efficiency of U4 
degradation (Figure 6). Addition of 20 fmol actin to the RNase H reaction resulted in nearly 
complete degradation of U4, while lower amounts of actin resulted in decreased U4 
degradation (Figure 6). 
While splicing extract contains factors that allow recycling of spliceosomal 
components for future rounds of splicing, the activity of these factors, and thus the number of 
splicing cycles that can be performed by a specific extract, is limited (Raghunathan and 
Guthrie, 1998). Therefore, it was important to ensure that the splicing performed during the 
RNase H reaction, while allowing increased U4 degradation, was not compromising the 
future splicing potential of the extract. Accordingly, I examined splicing in mock depleted 
extracts incubated with or without 20 fmol actin. Comparison of the splicing efficiencies of 
these extracts showed that the level of splicing that occurred during the RNase H reaction 
decreased the downstream splicing activity of the extract by less than 10% (Figure 10, lanes 
1-4). 
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Figure 5. The 5' end of U4 is more susceptible to RNaseH degradation under conditions 
of active splicing. Northern blot of U4 degradation in splicing extracts incubated at 
30 or 23°C in the presence or absence of 2 units RNase H, 20 fmol actin pre-mRNA, 
and lOuM JPS151. U4 degradation efficiency is indicated below the gel. 
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Figure 6. U4 degradation efficiency increases with the amount of actin pre-mRNA 
added to the reaction, a) Northern blot of U4 degradation in mock (lane 1) or U4-
depleted splicing extract (lanes 2-7) in the presence of the indicated amounts of actin 
pre-mRNA. U4 degradation efficiency is indicated below the gel. b) Correlation 
between U4 degradation efficiency and the amount of actin pre-mRNA present in the 
reaction. 
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Enzyme concentration is also an important factor when optimizing depletion of an 
RNA molecule using RNase H. In depletion of yeast U2 and U6 snRNAs (McPheeters et al. 
1989, Fabrizio et al. 1989), no exogenous RNase H was added because yeast splicing extract 
contains endogenous RNase H (Rymond and Rosbash 1986, Fabrizio et al. 1989, Newman 
1994). However, it is often beneficial to supplement RNase H depletion reactions with 
additional enzyme (Lamond and Sproat 1994). Therefore, I examined U4 degradation in the 
absence and presence of 2 units exogenous RNaseH and found that addition of enzyme 
improved degradation efficiency from 57.7% to 75.0% (Figure 5, lanes 3 and 4). As addition 
of 6 units RNase H did not improve degradation efficiency any further (Figure 8, lane 10), 2 
units RNase H was used in all remaining experiments presented in this section. 
Incubation temperature and time were varied to identify conditions that yield optimal 
U4 depletion. As with the previously discussed reaction parameters, these variables had to be 
optimized to yield maximum degradation efficiency while still allowing robust splicing. For 
example, although the optimal incubation temperature for an RNase H degradation reaction 
is 37°C (manufacturer recommendation), splicing extract becomes inactivated at elevated 
temperatures (Lin et al. 1985). Therefore, I examined U4 degradation at three different 
incubation temperatures. As shown in Figures 5 (lanes 4-7), 7 (lanes 2 and 3), and 8 (lanes 5-
8), 30°C resulted in better U4 degradation than 23°C. This was probably due to increased 
activity of the enzyme as it approached its optimal reaction temperature. However, 
degradation of U4 at the enzyme's optimal temperature of 37°C was actually less efficient 
than at 30°C (Figure 7, lanes 2 and 4). This was probably due to the fact that splicing 
activity, which, as shown above, is important for efficient U4 degradation, is maximal around 
room temperature and is inhibited at higher temperatures (Lin et al. 1985). Therefore, the 
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observed optimal temperature for U4 degradation of 30°C represents a balance of the optimal 
temperatures for both RNase H activity and splicing. I similarly examined the effect of 
incubation time on U4 degradation efficiency. As shown in Figure 8 (lanes 5 and 9), 
incubation of the RNase H reaction at 23°C for 3 hours did not result in better U4 
degradation than incubation at 30°C for 30 minutes. Furthermore, although I did not examine 
the effect of such an extended incubation on the extract's splicing capacity, activity would 
probably have been decreased due to increased degradation and denaturation of spliceosomal 
components. Therefore, I incubated all subsequent RNase H reactions for 30 minutes at 
30°C. 
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<r full-length U4 
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Figure 7. U4 degradation efficiency varies with the reaction temperature. Northern blot 
of U4 degradation in splicing extract incubated at 23, 30, or 37°C with the indicated 
concentrations of JPS151 and amounts of actin pre-mRNA. U4 degradation efficiency 
is indicated below the gel. 
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Figure 8. Effect of increased oligonucleotide concentration and incubation time on U4 
degradation efficiency. Northern blot of U4 degradation in splicing extract incubated 
at 30°C or room temperature with the indicated concentrations of JPS151 in the 
presence or absence of 20 fmol actin pre-mRNA. The degradation reaction in lane 9 
was incubated for 3 hours. The degradation reaction in lane 10 contained 6U RNase 
H. U4 degradation efficiency is indicated below the gel. 
The concentration of targeting DNA oligonucleotide is a critical parameter in RNase 
H depletion reactions; too low a concentration results in incomplete degradation of the target 
RNA, while too high a concentration can lead to nonspecific degradation of other RNAs in 
the extract (Lamond and Sproat 1994) and can also inhibit downstream reconstitution of the 
targeted RNA species. Given that the optimal concentration of DNA oligonucleotide depends 
on degradation efficiency and therefore must be determined empirically, I assessed a range of 
oligonucleotide concentrations. As shown in Figure 8 (lanes 3-5), oligonucleotide 
concentrations above lOuM did not improve U4 degradation. However, examination of 
oligonucleotide concentrations below lOuM showed that maximum U4 degradation was 
achieved with 5uM oligonucleotide (Figure 9, lanes 5-7). This oligonucleotide concentration 
is approximately 10-fold higher than that used by McPheeters et al. (1989) and Fabrizio et al. 
(1989) in the degradation of yeast U2 and U6, respectively. The disparity between these 
values suggests a significant difference in the accessibilities of the regions of the snRNA 
molecules being targeted. 
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Figure 9. Effect of decreased oligonucleotide and increased ATP concentrations on U4 
degradation efficiency. Northern blot of U4 degradation in splicing extract incubated 
with the indicated concentrations of ATP and oligo in the presence or absence of 20 
fmol actin pre-mRNA. U4 degradation efficiency is indicated below the gel. 
2.2.2 Inhibition of Spliceosome Assembly and Splicing by U4 Degradation 
A critical consideration in the development of an in vitro splicing reconstitution assay 
through RNase H degradation of U4 is that degradation of endogenous U4 must inhibit the 
splicing activity of the extract. As mentioned above, a previous attempt to develop such a 
system was unsuccessful because degradation of the chosen target sequence within U4 did 
not block splicing (Fabrizio and Abelson, unpublished results; Horowitz and Abelson 1993). 
In my study, I targeted a different region of U4, the 5' end, for degradation, resulting in 
efficient inhibition of splicing (Figure 10, lanes 5-8). Figure 11 shows that there is a close 
correlation between the fraction of U4 degraded in a splicing extract and inhibition of its 
splicing activity; 5 uM oligonucleotide provided the greatest U4 degradation and splicing 
inhibition. This correlation demonstrates the importance of achieving efficient U4 
degradation to effectively block splicing and subsequently allow clear observation of the 
activities of the U4 mutants. 
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Figure 10. Degradation of U4 inhibits splicing. Splicing of 32P-labeled actin pre-mRNA in 
extracts pre-treated with the indicated concentrations of oligo in the presence of 2 or 
lOmM ATP and in the presence or absence of 20 fmol unlabeled actin pre-mRNA. 
Lanes 9 and 10 are positive splicing controls and lane 11 is a negative splicing 
control. Splicing efficiency and splicing inhibition are indicated below the gel. 
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Figure 11. U4 degradation efficiency and splicing inhibition are closely correlated. 
Relationship between the fraction of U4 degraded and the degree of inhibition of 
splicing in samples 5-8 of Figures 9 and 10. 
To identify the point in the splicing cycle at which U4 degradation caused a block, I 
examined spliceosome assembly in mock-depleted and U4-depleted splicing extract (Figure 
12). While a time-course of spliceosome assembly in mock-depleted extract showed 
progression from pre-mRNA to the B complex and then the A complex, with appearance of 
mRNA at later time points (Figure 12a), examination of U4-depleted splicing extract showed 
that spliceosome assembly was blocked at the B complex (Figure 12b). Northern blot 
analysis confirmed the efficient degradation of U4 (Figure 12c). Only very low levels of the 
A complex were formed in the U4-depleted extract, and this was delayed compared to the 
mock-depleted extract. Consistent with denaturing gel analysis (Figure 10), no mature 
mRNA was formed in the U4-depleted extract (Figure 12b). These results suggest that Ul 
and U2 are able to associate with the pre-mRNA to form the B complex in the absence of an 
intact tri-snRNP, but further spliceosome assembly was blocked. 
The observation that partial spliceosome assembly can still occur in U4-depleted 
extract strongly contradicts the holospliceosome model of spliceosome assembly. Contrary to 
the traditional accretion model of spliceosome assembly, which states that the pre-mRNA 
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^M • % degraded 
interacts with individual snRNP particles in a stepwise manner (Figure 2), the 
holospliceosome model proposes that assembly occurs independently of the pre-mRNA and 
the pre-mRNA then interacts with a pre-formed penta-snRNP (Stevens et al .2002). Proposal 
of this model was prompted by the purification from yeast extract of a large particle 
containing the five snRNAs and 85% of all known splicing factors (Stevens et al .2002). 
When supplemented with micrococcal nuclease-treated extract, this particle was able to 
catalyze pre-mRNA splicing, and it did so as an intact particle that did not dissociate prior to 
binding the pre-mRNA (Stevens et al .2002). However, the results shown in Figure 12 
suggest that, while interaction of the pre-mRNA with a preformed penta-snRNP may indeed 
occur in some cases, positioning of Ul and U2 within such a particle is not a prerequisite for 
interaction of these snRNPs with the pre-mRNA. This result is supported by a study by 
Behzadnia et al. (2006) in which it was found that Ul and U2 were still able to interact with 
pre-mRNA in human nuclear extract that had been affinity depleted of U4 and U6 and thus 
could not support formation of a holospliceosome. Furthermore, these pre-spliceosomes were 
shown to be active in splicing, indicating that they were functional intermediates in the 
spliceosome assembly pathway (Behzadnia et al. 2006). Together, these results suggest that 
active spliceosomes can be assembled on pre-mRNA in a step-wise manner and thus 
interaction with a pre-formed penta-snRNP, as proposed by the holospliceosome model, is 
not required. 
27 
a) 
0 1 2 5 10 15 
• « • - -
w 
20 
<-pre-mRNA-$ 
^mRNA 
0 1 2 5 10 15 20 
it vil l i 
c) 
O C/D 
_E Q . 
**•« • «- full-length U4 
*•» <- RNase H product 
?"> % degraded 
Figure 12. U4 degradation blocks spliceosome assembly at the B complex. Time-course 
of formation of assembly complexes on 32P-labeled actin pre-mRNA in a) mock-
depleted or b) U4-depleted splicing extract analyzed by non-denaturing gel 
electrophoresis, c) Northern blot showing U4 degradation in the U4-depleted splicing 
extract (DSE) used in part b). 
A critical component of a splicing reaction is ATP, which serves as an energy source 
for the DEAD/DEXH-box proteins that catalyze RNA rearrangements within the 
spliceosome (Staley and Guthrie 1998). Previous examination of the effect of ATP 
concentration on splicing efficiency led to the current standard concentration of 2mM (Lin et 
al. 1985). However, Figure 11 shows that a significant increase in splicing efficiency was 
observed in the presence of a higher concentration of ATP (lOmM). Titration of ATP showed 
that maximum splicing was obtained using lOmM ATP, and that splicing efficiency 
decreased with further increases in ATP concentration (Figure 13). I therefore used lOmM 
ATP in all subsequent experiments. The discrepancy between the optimal ATP concentration 
reported by Lin et al. (1985) and that observed here may be explained by differences in the 
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ATP requirements of the molecular machinery used to splice the two different pre-mRNA 
transcripts. It is also possible that differences in splicing extract preparation led to a higher 
concentration of ATP-consuming molecules, a lower concentration of ATP-regenerating 
molecules, or a lower concentration of endogenous ATP in the extract used here compared to 
that of Lin etal (1985). 
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Figure 13. Maximum splicing efficiency is obtained with lOmM ATP. a) Splicing of actin 
pre-mRNA in reactions containing the indicated concentration of ATP. Splicing 
efficiency is indicated below the gel. b) Relationship between splicing efficiency and 
ATP concentration. 
One final factor I examined during optimization of the U4 degradation reaction was 
the length of the targeting DNA oligonucleotide. Initial experiments used an oligonucleotide 
complementary to the stem II region of U4 (nucleotides 1-19) (JPS151). I examined a second 
oligonucleotide complementary to U4 nucleotides 1-30 (SDR553) for its ability to direct 
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RNase H degradation of U4. As SDR553 extends into the 5' stem-loop, it produced a smaller 
degradation product than JPS151 (Figure 14). In addition, although the degradation 
efficiency of the two oligonucleotides was almost equal, the RNase H product of SDR553 
was less stable than that of JPS151 (Figure 14). This was probably because SDR553 disrupts 
the 5' stem-loop of U4, thereby making the remainder of the molecule more susceptible to 
degradation by endogenous nucleases in the extract. Conversely, U4 degradation directed by 
JPS151 leaves the 5' stem-loop intact, thereby increasing resistance of the RNA fragment to 
exonuclease degradation. Given these results, I used SDR553 as the targeting oligonucleotide 
in all subsequent experiments. More complete degradation of U4 would result in better 
release of any bound proteins into the extract, making them available for assembly onto IVT 
U4 in reconstitution experiments. Furthermore, interference by the RNase H product in 
subsequent reconstitution experiments would be less likely using SDR553 than JPS151. 
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Figure 14. A longer targeting oligonucleotide results in more complete U4 degradation. 
Northern blot of U4 degradation in splicing extract incubated with the indicated 
concentration of oligonucleotide complementary to U4 nucleotides 1-19 (JPS 151) or 
1-30 (SDR553). U4 degradation efficiency is indicated below the gel. 
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CHAPTER 3 
Identification of Optimal Conditions for Splicing Reconstitution in U4-
Depleted Extract and Examination of Reconstitution by U4 3' Truncation 
Mutants 
A critical requirement for development of a U4 reconstitution assay is that addition of 
WT IVT U4 to the U4-depleted extract must result in restoration of splicing activity. I 
therefore examined a variety of reaction conditions to identify those allowing maximal 
reconstitution of splicing. Once these conditions had been established, I used this assay to 
examine the activities of three different U4 3' truncation mutants. These experiments allowed 
identification of the minimum functional sequence of U4, and for the non-functional mutants, 
identification of where in the splicing cycle they caused a block. Together, these experiments 
further our understanding of the contributions of individual U4 snRNA functional domains to 
di-snRNP formation, spliceosome assembly, and splicing. 
3.1 Materials and Methods 
3.1.1 Stability and Activity of Reconstituted U4 snRNPs 
Following the RNase H degradation reaction, I added the indicated concentration of 
IVT U4 and incubated the mixture at 23°C for 6 minutes to allow the RNA to interact with 
its specific proteins and participate in di- and tri-snRNP formation. To assess the stability of 
the IVT U4,1 incubated the mixture at 23°C for a further 30 minutes, followed by addition of 
200uL stop solution and analysis by Northern blot as described above. To assess the ability 
of IVT U4 to reconstitute splicing activity, I added luL P-labeled actin pre-mRNA (4 fmol) 
to the extract following the 6 minute incubation, then incubated this reaction for a further 30 
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minutes at 23°C. Reactions were terminated by addition of 200uL stop solution and splicing 
activity was analyzed as described above. 
3.1.2 Reconstitution of U4/U6 Base-Pairing 
Following the RNase H degradation reaction, I added 300nM IVT U4 and incubated 
the mixture at 23°C for 6 minutes to allow interaction with U6 to occur. I then added 200uL 
stop solution and samples were phenol:chloroform extracted and ethanol precipitated as 
described above, except that the 5 minute incubation at 65°C following phenol:chloroform 
addition was omitted to avoid disruption of U6/U6 base-pairing. Precipitated RNA was 
resuspended in lOuL hybridization buffer (150mM NaCl, 50mM Tris-HCl (pH 7.4), ImM 
EDTA) and incubated for 15 minutes at 23°C with luL P-labeled oligonucleotide 
complementary to U4 (U4 14B) or U6 (SDR467). Samples were then mixed with 2uL 6x gel 
loading buffer (50% glycerol, trace bromophenol blue and xylene cyanol) and run 1 hour at 
300V at 4°C on a pre-cooled 9% non-denaturing polyacrylamide gel. The gel was then 
exposed to a phosphor screen at -80°C. 
To calculate annealing efficiency, autoradiograms were visualized and quantified 
using a Cyclone© phosphoimager and Optiquant© software (Packard Instruments). 
Annealing efficiency was calculated from the U6-probed samples by dividing the intensity of 
the U4/U6 band by the total intensity of both bands (U4/U6 and free U6). 
3.1.3 Generation of U4 3' Truncation Mutants 
I generated templates for transcription of the mutants by PCR from the U4-containing 
plasmid pT7U4. For all mutant templates, the same forward primer, containing the T7 
promoter (indicated in bold), was used 
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SDR591 
5' AATTAATACGACTCACTATAGGGATCCTTATGCACGGGAAATA 3' 
The reverse primers used were 
SDR592 (for U4 1-68) 
5' TTTCAACCAGCAAAAACA 3' 
SDR593 (for U4 1-142) 
5' CCCTACATAGTCTTGAAGTATTCA 3' 
SDR595 (for U4 1-90) 
5' GACGGTCTGGTTTATAATTAAATTTCA 3' 
PCR products were purified on a 6% denaturing polyacrylamide gel prior to their use 
as templates in standard in vitro transcription reactions using the MEGAshortscript kit 
(Ambion 2008). Transcript was purified on a 6% denaturing polyacrylamide gel. 
3.1.4 Reconstitution of Splicing, Spliceosome Assembly, and U4/U6 Base-Pairing by the 
U4 3' Truncation Mutants 
I analyzed reconstitution of splicing and di-snRNP formation by the U4 3' truncation 
mutants as described previously for WT U4. Reconstitution of spliceosome assembly was 
analyzed as described previously, except that 300 nM WT or mutant IVT U4 was added to 
the U4-depleted splicing extract prior to the 30 minute incubation with 32P-labeled actin pre-
mRNA, and assembly complexes were separated by electrophoresis on a 4% non-denaturing 
polyacrylamide (80:1) gel in IX TGM buffer (50mM tris base, 50mM glycine, 2mM MgCl2) 
for 3 hours at 160V at 4°C. 
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3.2 Results and Discussion 
3.2.1 Optimal Conditions for Splicing Reconstitution in U4-Depleted Extract 
Previous experiments showed that targeting DNA oligonucleotide concentrations 
below 5uM did not efficiently degrade U4 or inhibit splicing (Figures 9 and 10). However, 
by using a new preparation of cold actin pre-mRNA to generate splicing conditions during 
the RNase H reaction, I saw efficient U4 degradation and splicing inhibition by as little as 
0.5|JM DNA oligonucleotide (Figure 15). Presumably, the better-quality actin resulted in 
increased splicing and thus more efficient release of free U4 snRNP, allowing a ten-fold 
reduction in the required concentration of targeting oligonucleotide. This oligonucleotide 
concentration is comparable to the 0.45 and 0.1-0.3uM concentrations reported for the 
degradation of yeast U2 and U6, respectively (McPheeters et al. 1989, Fabrizio et al. 1989). 
Underscoring the importance of performing U4 degradation under splicing conditions, Figure 
15 also shows that, in the absence of splicing (lane 2), 5uM targeting oligonucleotide was 
required to achieve the level of degradation efficiency produced by 0.05uM targeting 
oligonucleotide in the presence of splicing (lane 5). Thus, performing U4 degradation under 
splicing conditions decreased the required oligonucleotide concentration by 100-fold. 
Successful development of an in vitro splicing reconstitution assay requires that the 
method used for depletion of the target snRNA does not also cause depletion of the 
subsequently added IVT RNA. Although 5 and 0.5uM targeting oligonucleotide allowed 
efficient degradation of endogenous U4, they also result in nearly complete degradation of 
the IVT U4 (Figure 15, lanes 3, 4, 8, and 9). While degradation of IVT U4 is decreased in 
splicing extract containing 0.05uM targeting oligonucleotide, this oligonucleotide 
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concentration is not sufficient for efficient degradation of endogenous U4 (Figure 15, lanes 5 
and 9). 
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Figure 15. Lower oligonucleotide concentrations improve IVT U4 stability. Northern blot 
showing degradation of endogenousU4 (lanes 1-5) and stability of 50 fmol IVT U4 in 
the presence of the indicated concentrations SDR553. The RNase H reaction in lane 2 
was performed under non-splicing conditions. Lane 6 contains only 50 fmol IVT U4. 
The fraction of endogenous or IVT U4 degraded in each reaction is indicated below 
the gel. 
Based on the results shown in Figure 15, I examined a range of targeting 
oligonucleotide concentrations between 0.05 and 0.5uM in an attempt to identify a 
concentration that allowed efficient degradation of endogenous U4 but not IVT U4 (Figure 
16). However, oligonucleotide concentrations below 0.5uM resulted in a decreased U4 
degradation efficiency and were therefore less effective at blocking splicing (Figure 16, lanes 
2 and 3). 
Given that previous studies achieved RNase H degradation of snRNAs in yeast 
extract without additional enzyme (McPheeters et al. 1989, Fabrizio et al. 1989), I re-
examined U4 degradation in the absence of exogenous RNase H (Figure 16, lane 5). Contrary 
to initial results (Figure 5), I found the efficiency of U4 degradation and splicing inhibition 
with 0.5uM oligonucleotide to be independent of exogenous RNase H (Figure 16, lanes 4 
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and 5). Again, this change may have been due to the use of better-quality actin, which would 
have increased accessibility of the 5' end of U4 and thereby decreased the RNase H 
concentration required for interaction with, and subsequent degradation of, this region of U4. 
Importantly, IVT U4 was more stable in extract depleted of U4 without additional RNase H 
(Figure 16a, lanes 10 and 11). Therefore, subsequent reactions contained 0.5uM 
oligonucleotide and no exogenous RNase H. 
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As suggested by the improved stability of IVT U4, these U4 depletion conditions 
(0.5uM oligonucleotide and no exogenous RNase H) allowed successful reconstitution of 
splicing in U4-depleted extract following addition of IVT U4 (Figure 17a). The efficiency of 
splicing in mock-depleted extract, 58.9%, was decreased to 5.4% upon depletion of 
endogenous U4, and restored to 18.5% by addition of IVT U4 (Figure 17a). Titration of IVT 
U4 showed that maximum reconstitution was achieved by the addition of 300nM IVT U4 
(Figure 17b). The decrease in reconstitution efficiency by IVT U4 concentrations above 
300nM may be due to increased competition for U4-specific proteins, effectively diluting the 
proteins available, such that fewer U4 RNA molecules receive the full protein complement 
needed to be functional. 
The concentration of IVT U4 found here to be required for maximum reconstitution 
was substantially higher than the values reported for maximum reconstitution of yeast U2 
(40nM) and U6 (lOnM), despite the fact that the latter two snRNAs are found at a higher 
endogenous concentration in splicing extract (McPheeters et al. 1989, Fabrizio et al. 1989). 
Specifically, the concentration of IVT U4 required here for maximum reconstitution was 
approximately 150-fold higher than the concentration of endogenous U4 present in the mock-
depleted splicing extract (determined by Northern blot analysis comparing to IVT U4 
standards, data not shown), while the concentrations of yeast U2 and U6 required for 
maximum reconstitution were approximately eight- and two-fold the endogenous levels, 
respectively (McPheeters et al. 1989, Fabrizio et al. 1989). 
There are several possible explanations for the substantially higher concentration of 
in vitro transcript required for reconstitution of U4 compared to U2 and U6. One possibility 
is that a higher proportion of IVT U4 was degraded by nucleases upon addition to extract. 
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Since a higher concentration of targeting oligonucleotide was used to deplete U4 than U2 and 
U6 (0.5 uM compared to 0.1-0.3 uM and 0.45 uM, respectively (McPheeters et al. 1989, 
Fabrizio et al. 1989)), a higher concentration of the oligonucleotide may have remained in 
the extract at the time of IVT U4 addition, causing a greater fraction of the IVT U4 to be 
degraded by residual RNase H activity. Furthermore, differences in extract preparations may 
have led to higher levels of endogenous DNase activity in the extracts of McPheeters et al. 
(1989) and Fabrizio et al. (1989) compared to the extracts I used, contributing to decreased 
degradation of the DNA oligonucleotide and therefore increased degradation of IVT U4. 
It is also possible that, due to sequence and conformational differences between the 
three snRNAs, IVT U4 may be more susceptible to degradation by nucleases in the extract 
than U2 or U6. Since the snRNAs are stabilized by interaction with their specific proteins, it 
may be that U2 and U6 form such interactions more readily than U4. Another possibility is 
that only a fraction of the IVT U4 was in an active conformation, and that this fraction was 
lower than that for U2 or U6. One possible source of such inactivity is misincorporation by 
T7 RNA polymerase during transcription. Although the error rate of this enzyme is low 
(Huang et al. 2000), it has been shown to have increased susceptibility to slippage when 
transcribing regions of a template with extended stretches of adenosine or thymine (Reyes 
and Abelson 1988). As the U4 template contains a number of regions composed entirely of 
adenosine and thymine, up to 15 nucleotides in length, such errors may have contributed to 
the non-functionality of a significant portion of the IVT U4. Finally, inactivation of a portion 
of U4 may have been caused by incorrect folding of the in vitro transcript. Indeed, the 
separation of IVT U4 by non-denaturing gel electrophoresis suggested that the majority of 
this molecule may in fact adopt a conformation different from that of endogenous U4 (Figure 
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19, lane 4). As IVT U4 runs as a single band when analyzed on a denaturing gel (Figures 15 
and 16, lane 6), this observation supports the hypothesis that the two IVT U4 bands seen 
under non-denaturing conditions do indeed reflect a conformational difference and not a 
difference in transcript length. It would be expected that increasing the fraction of correctly 
folded U4, such as through glycerol gradient purification, would decrease the concentration 
of U4 necessary for maximum splicing reconstitution. 
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Figure 17. Splicing in U4-depleted extract is reconstituted by IVT U4. a) Splicing in 
mock depleted (lane 1) or U4-depleted (lanes 2 and 3) splicing extract in the absence 
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concentration of IVT U4 and the level of splicing reconstituted. 
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As efficiency of splicing reconstitution is a measure of the fold increase in splicing in 
U4-depleted splicing extract upon addition of IVT U4, I examined a number of 
oligonucleotide concentrations around 0.5uM for any concentrations that amplified the 
difference between splicing efficiency before and after IVT U4 addition. While a lower 
oligonucleotide concentration resulted in a substantially smaller increase in splicing upon 
reconstitution (Figure 18), slightly higher oligonucleotide concentrations improved 
reconstitution efficiency, with 0.8uM oligonucleotide giving the largest increase at 35.6-fold 
above the U4-depleted extract (Figure 18). Therefore, subsequent U4 degradation reactions 
were performed using 0.8uM targeting oligonucleotide. 
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As U4 forms an extensive base-pairing interaction with U6,1 examined its disruption 
by U4 depletion and reconstitution by addition of IVT U4 by non-denaturing gel 
electrophoresis. Figure 19 shows that U4 degradation effectively eliminated detection of the 
di-snRNA species, which was reconstituted by incubation with IVT U4. As an extended 
incubation period did not improve the efficiency of U4/U6 reconstitution (Figure 19, lanes 5 
and 10), a six minute incubation was used in subsequent experiments. 
While reconstituted samples probed for U6 showed a clear re-formation of the di-
snRNA, reconstituted samples probed for U4 showed only a very faint band at the position of 
U4/U6 (Figure 19, lanes 4 and 5). Although the 3' region of U4 bound by the probe should be 
equally accessible in the free U4 and U4/U6 species, if free U4 was preferentially bound, this 
may have led to a shortage of probe available to bind U4 in the di-snRNA, resulting in the 
observed lack of U4/U6 signal in these samples. Given the clear disruption of U4/U6 in U4-
depleted extract and reconstitution of this species by addition of IVT U4 when the base-
pairing status of U6 is observed (Figure 19, lanes 8-10), subsequent experiments examining 
reconstitution of U4/U6 were performed using a U6 probe. 
As discussed above, probing for U4 revealed that a substantial portion of the IVT U4 
added to the U4-depleted splicing extract was in an alternate conformation which migrated 
more slowly than the endogenous U4 (Figure 19, lanes 4 and 5). If such a conformation is 
nonfunctional, then separation of this species from the correctly folded U4 prior to 
reconstitution would substantially reduce the U4 concentration required for maximum 
splicing reconstitution. 
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Figure 19. U4/U6 base-pairing in U4-depleted splicing extract is reconstituted by IVT 
U4. Non-denaturing gel showing the base-pairing status of U4 (lanes 1-5) and U6 
(lanes 6-10) in untreated splicing extract (SE), mock depleted splicing extract, or U4-
depleted splicing extract (DSE) in the absence or presence of 300 nM IVT U4 and 
incubated for 6 or 15 minutes. The percent of U6 base-paired to U4 is shown below 
the gel. 
3.2.2 Analysis of U4 3' Functional Domains 
3.2.2.1 Phylogenetic and Mutational Analysis of the 3' Portion of U4 snRNA 
As functionally significant regions of biomolecules are under greater selective 
pressure and therefore display stronger evolutionary conservation, phylogenetic analysis is a 
valuable means of identifying functionally important domains of these molecules. Such 
analysis of U4 snRNA reveals considerable variation of conservation across the molecule. 
While the 3' half of U4 is generally less well conserved than the 5' portion (Guthrie and 
Patterson 1988, Myslinski and Branlant 1991), certain regions within the 3' portion do 
display a significant level of conservation. 
One highly conserved region in the 3' portion of U4 is the poly-uridine tract (Guthrie 
and Patterson 1988, Myslinski and Branlant 1991) that serves as a binding site for the Sm 
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proteins (Figure 20), which are important for nuclear localization of the snRNA (Fischer et 
al. 1993). Accordingly, deletion of the Sm-binding site blocks splicing in vivo, since the 
snRNA is not localized to the nucleus (Vankan et al. 1990). Similarly, point mutations in the 
Sm-binding site of yeast U4 are lethal or conditionally lethal in vivo (Hu et al. 1995). 
However, the Sm-binding site was not found to be required for spliceosome assembly or 
splicing in vitro in human nuclear extract (Wersig and Bindereif 1990, 1992). 
The 3' stem-loop is a highly variable domain of U4, both in size and sequence 
(Guthrie and Patterson 1988, Myslinski and Branlant 1991) (Figure 20). Consistent with this 
extreme phylogenetic variability, Vankan et al. (1990) demonstrated this region to be 
dispensable for splicing in Xenopus oocytes. Similarly, Wersig and Bindereif (1990, 1992) 
showed that this region of human U4 is not essential for spliceosome assembly or splicing in 
human nuclear extract, although its deletion does cause a reduction in splicing activity. 
Conversely, using an in vivo assay, Bordonne et al. (1990) found the 3' stem-loop to be an 
essential element of U4 in yeast; substitution with the comparable region of Trypanosoma 
brucei U4 resulted in significant inhibition of di-snRNP assembly and was lethal. Similarly, 
in vivo experiments by Hu et al. (1995) found that deletion of nucleotides 131-133 within the 
3' stem-loop of yeast U4 resulted in conditional lethality. The incongruence of these results 
may reflect differences in the splicing mechanisms of the organisms being studied, such as 
the mechanism of di-snRNP formation; differences between the in vivo and in vitro assays 
used; or simply differences in the snRNA sequence requirements for splicing of the pre-
mRNAs being studied (Vankan et al. 1990). 
A second highly conserved sequence in the 3' portion of U4 is the 5' region of the 
single-stranded central domain (Vankan et al. 1990, Guthrie and Patterson 1988) (Figure 20). 
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Consistent with its conservation, deletion of this sequence strongly inhibits splicing in human 
nuclear extract and Xenopus oocytes, while deletions in the remaining portion of the central 
domain have a substantially decreased effect on splicing (Wersig and Bindereif 1992, 
Vankan et al. 1992). Interestingly, deletion of the entire central domain of yeast U4 resulted 
in only a mild conditional growth defect (Hu et al. 1995), again suggesting differences in the 
U4 sequence requirements of these organisms. 
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Figure 20. U4 3' truncation mutants. Secondary structure of U4 (yellow) in the di-snRNA 
with positions used to generate U4 3' truncation mutants indicated by arrows. 
3.2.2.2 Reconstitution of Splicing, Spliceosome Assembly, and U4/U6 Base-Pairing by 
U4 3' Truncation Mutants 
Given the above analyses of U4 3' domains required for splicing, as well as the 
observation that the 5' stem-loop and stems I and II are all required for efficient spliceosome 
assembly and splicing (Wersig and Bindereif 1990, 1992; Vankan et al. 1990), I began my 
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search for the minimum U4 sequence able to support splicing by examining a U4 mutant 
containing only nucleotides 1-68. This mutant lacked the Sm-binding site, the 3' stem-loop, 
and most of the central domain (Figure 20), though it did contain the 5' portion of the central 
domain identified by Wersig and Bindereif (1992) and Vankan et al. (1992) as being 
important for splicing activity. I generated the template for transcription of this mutant by 
PCR, as described in the methods, and tested its ability to participate in splicing. 
To examine the effect of removing the 3' end of U4, I added the truncated U4 
transcript to extract depleted of endogenous U4 and assessed its ability to restore splicing of 
pre-mRNA. Unexpectedly, addition of U4 1-68 to the U4-depleted extract did not result in 
any reconstitution of splicing activity (Figure 21, lane 5). To confirm that the extract was 
functional, I also examined addition of WT U4, which restored splicing to 15.3% from 1.2% 
in the U4-depleted extract (Figure 21, lane 3). In mock depleted extract, 57.2% of the pre-
mRNA was spliced. These results establish that the extract was active, that splicing was 
successfully blocked by depletion of endogenous U4 and reconstituted by addition of WT 
IVT U4, and therefore that the failure of U4 1 -68 to restore splicing, while a negative result, 
was nevertheless credible. 
Lack of splicing reconstitution by U4 1-68 may have been due to the absence of the 3' 
portion of the central domain. While not as important for splicing as the 5' region of the 
central domain, deletion of this sequence still had an appreciable effect on splicing (Wersig 
and Bindereif 1992). Therefore, I synthesized a longer 3' truncation mutant containing the 
entire central domain (U4 1-90, Figure 20) and examined its activity using the reconstitution 
assay. However, Figure 21 (lane 6) shows that this mutant also was unable to reconstitute 
splicing. 
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The final U4 3' truncation mutant I examined, U4 1-142, was truncated just 3' of the 
3' stem-loop and thus lacked the Sm protein binding site (Figure 20). Consistent with 
reconstitution studies in human nuclear extract (Wersig and Bindereif 1992), I found this 
region of yeast U4 to be dispensable for splicing in vitro, as it yielded an approximately 10-
fold increase in splicing over the U4-depleted extract (Figure 21, lane 4). 
Together, these results suggest that the function of the U4 Sm proteins is largely 
limited to proper cellular localization of the snRNP in vivo, with no further roles that are 
required for splicing in vitro. In contrast, examination of the Ul snRNP has shown that the 
Sm proteins are essential for snRNP assembly (Hamm et al. 1990), and a recent crystal 
structure of the Ul snRNP has shown that this is due to their role in stabilizing RNA 
structures required for further protein assembly (Krummel et al. 2009). Thus, the results of 
this study highlight important differences between the mechanisms of protein assembly 
during the biogenesis of different snRNAs. 
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Figure 21. Splicing is reconstituted by U4 1-142, but not U4 1-68 or U4 1-90. Splicing in 
mock depleted (lane 1) or U4-depleted (lane 2-6) splicing extract in the absence (lane 
2) or presence of 300nM IVT WT (lane 3) or 3' truncated (lanes4-6) U4. Lanes 7 and 
8 are positive and negative splicing controls, respectively. Splicing efficiency and 
fold increase in splicing upon reconstitution are shown below the gel. 
While the lack of splicing reconstitution by U4 1-68 and 1-90 may have been due to 
exclusion of a functionally essential region of the molecule, it may also have resulted from 
decreased stability of these mutants in splicing extract. To investigate this possibility, I used 
Northern blot analysis to examine the stability of WT and mutant IVT U4 snRNA in U4-
depleted splicing extract. Figure 22 shows that approximately half of the WT IVT U4 added 
to U4-depleted splicing extract remained at the end of the reconstitution assay (lanes 1 and 
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5). This is similar to the stability of IVT U2 in U2-depleted yeast extract, where 
approximately 35% of the input RNA was stable during the reconstitution assay (McPheeters 
et al. 1989). While previous studies report the stabilities of WT and mutant snRNAs during 
the reconstitution assay to be roughly similar (McPheeters et al. 1989, Fabrizio et al. 1989, 
Wersig and Bindereif 1992), I observed decreased stability of the mutants relative to WT U4 
(Figure 22). However, lack of reconstitution by U4 1-68 and 1-90 cannot be entirely 
attributed to transcript degradation, since U4 1-90, which was more stable than U4 1-142, did 
not reconstitute splicing, while U4 1-142 did (Figures 21 and 22). This suggests that the 
inability of U4 1-90 to reconstitute splicing was not due to a lack of stability; rather, the 
results suggest that this mutant lacks some functionally essential component of U4. 
Furthermore, while U4 1-68 was the least stable of the mutants (Figure 22), the inactivity of 
U4 1-90 implies that this even-shorter mutant would be unable to reconstitute splicing even if 
it was completely stable during the reconstitution assay. 
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Figure 22. Stability of U4 mutants in U4-depleted splicing extract is variable. Northern 
blot showing stabilities of WT and mutant IVT U4 in the absence (lanes 1-4) or 
presence (lanes 5-8) of U4-depleted splicing extract (DSE). U4 degradation efficiency 
is indicated below the gel. 
To further explore the lack of splicing reconstitution by U4 1-68 and 1-90 in U4-
depleted extract, I investigated the ability of these mutants to reconstitute spliceosome 
assembly (Figure 23). Figure 12 shows that degradation of U4 blocks spliceosome assembly 
at complex B and prevents accumulation of mature mRNA (Figure 23, lane 4). Addition of 
WT U4 or U4 1-142 restored formation of complex A and mature mRNA, while addition of 
U4 1-68 or 1-90 did not (Figure 23, lanes 5-8). These results suggest that the lack of splicing 
reconstitution by U4 1-68 and 1-90 is due to an inability of these mutants to participate in 
spliceosome assembly. 
Furthermore, this experiment suggests that regions of U4 beyond the U6-activating 
sequence predicted by the Dunn-Rader model (U4 stem II, see Figure 4) are required for 
stable binding of U6 to the pre-mRNA. If the U4 3' truncation mutants containing stem II had 
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been sufficient for U6/pre-mRNA interaction, even if further spliceosome assembly was 
blocked, accumulation of a band between complexes H and B, corresponding to a 
U4/U6/pre-mRNA complex, would have been expected. The absence of such a band (Figure 
23) suggests that either such a complex did not form, or if it did form, the absence of the 
deleted sequences and any associated protein factors caused the complex to be too unstable to 
be detected using this technique. Hence, the results of this experiment do not support the 
most direct prediction of the Dunn-Rader model of free U6, namely that the stem II region of 
U4 should be sufficient to open up U6 for interaction with pre-mRNA. This suggests that, if 
the Dunn-Rader model is correct, either the 3' portions of U4 or their associated proteins are 
also important for U6 activation. 
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Figure 23. Formation of complex A is reconstituted by U4 1-142, but not by U4 1-68 or 
U4 1-90. Non-denaturing gel showing the assembly of spliceosomal complexes A and 
B on 32P-labeled actin pre-mRNA incubated in splicing extract for the indicated times 
(lanes 1-3) or in U4-depleted splicing extract for 30 minutes (lanes 4-8) in the 
absence (lane 4) or presence (lanes5-8) of 300 nM WT or mutant IVT U4. 
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The lack of reconstitution of complex A formation by U4 1-68 and 1-90 could have 
been due to an inability of the mutants to interact with U6, an inability of the di-snRNP 
formed by U6 and the U4 mutants to interact with U5 to form a functional tri-snRNP, or an 
inability of the U4 mutant-containing tri-snRNP to interact with the pre-mRNA. To 
distinguish among these possibilities, I examined interaction between the U4 mutants and 
U6. Figure 24 shows that, while WT U4 and U4 1-142 were able to reconstitute formation of 
the di-snRNP in U4-depleted extract, U4 1-68 and 1-90 were not. Hence, the inability of U4 
1-68 and 1-90 to reconstitute splicing stems from an inability to interact with U6. 
Furthermore, the ability of U4 1-142, but not U4 1-90, to interact with U6 implies that the 3' 
stem-loop plays an essential role in formation of the di-snRNP. Given this result, it was 
impossible to draw any conclusions regarding the validity of the Dunn-Rader structural 
model of free U6 from these reconstitution experiments; while it is possible that only U4 
stem II is required to expose the pre-mRNA-binding sequence of U6, a larger region of U4 is 
apparently necessary to establish U4/U6 interaction in the first place, thereby preventing 
separation of these two functions. 
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Figure 24. U4/U6 base-pairing is reconstituted by U4 1-142, but not U4 1-68 or U4 1-90. 
Non-denaturing gel showing the base-pairing status of U6 in mock depleted splicing 
extract (lane 1) or U4-depleted splicing extract (lanes 2-6) in the absence (lanes 1 and 
2) or presence (lanes 3-6) of 300 nM WT or mutant IVT U4. The percent of U6 base-
paired to U4 is shown below the gel. 
The inability of U4 truncation mutants lacking the 3' stem-loop to form the U4/U6 di-
snRNP prevented use of the reconstitution assay to investigate whether this region may also 
function at later steps of spliceosome assembly or splicing. To investigate a possible role for 
this domain beyond di-snRNP formation, I performed RNase H degradation of the central 
domain of U4 under non-splicing conditions (unlabeled actin pre-mRNA was omitted), such 
that the U4/U6 interaction was maintained. This reaction produced a di-snRNP particle 
containing U6 base-paired to a U4 fragment composed of stems I and II and the intervening 
5' stem-loop (Figure 20). Truncation of U4 was confirmed by Northern blot analysis (Figure 
25a, lane 3) and association with U6 was confirmed by non-denaturing gel electrophoresis 
(data not shown). Addition of 32P-labeled actin pre-mRNA showed that the di-snRNP 
containing this 5' portion of U4 was able to participate in splicing (Figure 25b, lane 3). 
However, if the U4 degradation reaction was performed under conditions of active splicing 
such that the U4/U6 interaction was disrupted (confirmed by non-denaturing gel 
54 
electrophoresis, data not shown), the same U4 fragment was produced (Figure 25a, lane 2), 
but subsequent splicing of P-labeled actin pre-mRNA was blocked (Figure 25b, lane 2). 
Hence, extract containing the truncated form of U4 was only able to support splicing if U4 
remained bound to U6; if the truncated U4 was dissociated from U6 prior to addition of 32P-
labeled actin pre-mRNA, splicing was blocked. It is interesting to note that splicing 
efficiency in extract containing the 5' portion of U4 still bound to U6 was approximately 
three-fold lower than that in mock-depleted extract containing WT U4 (Figure 25b, lanes 1 
and 3). Given that disruption of the interaction between U6 and the 5' fragment of U4 
blocked subsequent splicing (Figure 25b, lane 2), these results suggest that the observed 
difference in splicing efficiency between lanes 1 and 3 of Figure 25b may reflect the ability 
of the truncated U4-containing di-snRNP to support only a single round of splicing, while 
WT U4 was able to reanneal to U6 to allow multiple rounds of splicing. Taken together, 
these results indicate that, while the portion of U4 3' of stem I is required for interaction with 
U6, it does not contribute to later steps of spliceosome assembly or splicing catalysis. This is 
consistent with previous experiments presented here that suggest that the 3' stem-loop plays a 
critical role in di-snRNP formation. 
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Figure 25. Degradation of the central domain of U4 under splicing conditions, but not 
non-splicing conditions, blocks subsequent splicing, a) Degradation of U4 in 
mock-depleted or U4-depleted (DSE) splicing extract by incubation with 0.8 ^M 
U4CM3 (complementary to U4 nucleotides 65 to 88) under splicing (sc) or non-
splicing (nsc) conditions. Degradation efficiency is shown below the gel. b) Effect of 
U4 degradation on subsequent splicing of 32P-labeled actin pre-mRNA. Lanes 4 and 5 
are positive and negative splicing controls, respectively. Splicing efficiency of each 
reaction is shown below the gel. 
The lack of reconstitution of di-snRNP formation by U4 mutants lacking the 3' stem-
loop (U4 1-68 and 1-90) was unexpected. This is because reconstitution studies in human 
nuclear extract and Xenopus oocytes have shown that deletion of the Sm-binding site, the 3' 
stem-loop, or the entire central domain does not significantly inhibit U4/U6 interaction 
(Wersig and Bindereif 1990, 1992; Vankan et al. 1990). However, the results presented here 
are consistent with a study by Bordonne et al. (1990) in which substitution of the yeast U4 3' 
stem-loop by that from Trypanosoma brucei U4 snRNA decreased interaction with U6 by 
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60-70% and was lethal. Similarly, Hu et al. (1995) report a deletion within the yeast U4 3' 
stem-loop that confers conditional lethality. Together, these results suggest a significant 
difference between the functionally essential regions of U4 in humans and yeast. 
The reason for this apparent requirement of the U4 3' stem-loop for di-snRNP 
formation in yeast is unclear. This region of the molecule has not been implicated in protein 
binding, though limited structural knowledge of the U4 snRNP does not allow exclusion of 
this possibility. The U4-associated protein Snul3 has been shown to interact directly with the 
U4 snRNA through the 5' stem-loop (Nottrott et al. 1999, Vidovic et al. 2000). Similarly, UV 
cross-linking has indicated that Prp31 contacts U4 nucleotides within and directly upstream 
of the 5' stem-loop (Nottrott et al.2002). While the putative U4 snRNP protein Prp4 has been 
shown to require the 5' region of the snRNA for addition to the di-snRNP (Bordonne et al. 
1990, Xu et al. 1990), direct binding of Prp4 to U4 snRNA has not been demonstrated. As 
well, the binding site for Prp3, also a potential U4-associated protein (Anthony et al. 1997, 
Ayadi et al. 1998), has not yet been identified. It may be that one of these proteins, or another 
as-yet unidentified splicing factor, interacts with U4 through the 3' stem-loop, either 
exclusively or in addition to interaction with the 5' region of the molecule. 
It is also possible that the 3' stem-loop itself is required for folding of the RNA into 
the correct secondary structure by preventing formation of competing, non-functional 
conformations, or that it participates in stabilization of the correct tertiary structure through 
formation of A-minor interactions with other regions of the molecule. A-minor interactions, 
involving interaction of a stack of single-stranded nucleotides, usually adenosines, with the 
minor groove of a helix, are a common form of helix packing in RNA molecules (Daherty et 
al. 2001). Thus, it is possible that interaction of the 3' stem-loop with a single-stranded, 
57 
adenosine-rich region, such as the 3' portion of the central domain (Figure 3), is required for 
the subsequent U4 snRNA interactions leading to di-snRNP formation, spliceosome 
assembly, and splicing. Whatever the function of the 3' stem-loop in yeast, the dispensability 
of this domain for splicing in human nuclear extract and Xenopus oocytes (Wersig and 
Bindereif 1992, Vankan 1990) suggests that the function is either not required in these 
systems or has been replaced by a splicing factor not present in yeast. Future U4 
reconstitution analyses will be aimed at investigating the role of the 3' stem-loop in snRNP 
formation (see Chapter 5 for further discussion). 
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CHAPTER 4 
Identification of Optimal Conditions for Reconstitution of Functional U6 
snRNPs and Generation of U4/U6-Depleted Extract 
The development of a system for in vitro reconstitution of functional U4 snRNPs , as 
described in Chapter 3, opens the door to a large number of experiments probing the structure 
and function of the U4 snRNP. One of the questions which this system may be used to 
investigate is how formation of the U4/U6 di-snRNP is initiated. As discussed in Section 
1.6.1, it has been proposed that these snRNAs first interact through complementary 
nucleotides located in loop structures at the 5' end of U4 and the 3' end of U6 (Figure 3b), 
initiating formation of stems I and II (Karaduman et al. 2006; Ollenberger and Rader, 
unpublished results). This kissing-loop hypothesis could be tested using in vitro 
reconstitution by first mutating U4's loop residues in a way predicted to block di-snRNP 
formation, and then reconstituting extract depleted of both U4 and U6 with the mutant U4 
and a U6 containing compensatory mutations and examining their ability to base-pair. If the 
kissing-loop model is correct, and if the mutated residues do not play a role beyond the 
U4/U6 interaction, di-snRNP formation and splicing activity should be restored. Restoration 
of the U4/U6 interaction but continued blockage of splicing would still support the kissing-
loop model, but would also indicate that the mutated residues play a role beyond initiation of 
di-snRNP formation. Thus, examination of the kissing-loop hypothesis requires a system for 
depletion and reconstitution of both U4 and U6 at the same time. To this end, I identified 
conditions allowing both optimal reconstitution of U6 snRNPs and efficient generation of 
U4/U6 depleted splicing extract. 
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4.1 Materials and Methods 
4.1.1 RNase H Degradation and Reconstitution of U6 
RNase H degradation of U6 was performed as described for U4, except this reaction 
was not carried out under conditions of active splicing (unlabeled actin pre-mRNA was 
omitted) and the targeting oligonucleotide used was: 
SDR419 (complementary to U6 nucleotides 28 to 54) 
5' ATCTCTGTATTGTTTCAAATTGACCAA 3' 
Reactions were incubated for 30 minutes at 30°C. 
Reconstitution of splicing in U6-depleted splicing extract by IVT U6 was examined 
as for U4, except that, where indicated, a blocking oligonucleotide complementary to the 
targeting oligonucleotide was added following RNase H degradation, prior to addition of IVT 
U6. The sequence of this blocking oligonucleotide was: 
SDR588 
5' TTTGAAACAATACAG 3' 
4.1.2 Generation of U4/U6-Depleted Splicing Extract 
Splicing extract depleted of both U4 and U6 was generated by first degrading U4 as 
described previously and then adding U6 targeting oligo and incubating the reaction for an 
additional 30 minutes at 30°C. Degradation efficiency was analyzed by Northern blot as 
described previously. 
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4.2 Results and Discussion 
4.2.1 Optimal Conditions for Reconstitution of Functional U6 snRNPs 
A system for in vitro reconstitution of functional U6 snRNPs has been described 
previously (Fabrizio et al. 1989). Therefore, I performed initial U6 reconstitution attempts 
according to this protocol. However, while Fabrizio et al. (1989) report efficient 
reconstitution of splicing with lOnM IVT U6, I did not observe reconstitution with IVT U6 
concentrations up to lOOnM (Figure 26, lanes 3 and 4). In a more recent study employing in 
vitro reconstitution of functional U6, McGrail et al. (2006) report that a blocking 
oligonucleotide complementary to the targeting oligonucleotide was added to U6-depleted 
splicing extract prior to addition of IVT U6. I also found that use of a blocking 
oligonucleotide allowed successful reconstitution of splicing in U6-depleted extract (Figure 
26, lanes 5 and 6). However, the level of splicing reconstituted (10-20% compared to the 
mock-depleted extract) was significantly lower than that reported by Fabrzio et al. (1989) 
(50-100%, using lOnM IVT U6). 
61 
+588 
M
U
6 
n
M
U
6 
M
U
6 
n
M
U
6 
c o c o o o o o r—H j--H i—H 1—H 
1^ + + + + 
o w a u w w O W W W 75 Cfl 
S Q Q Q Q Q 
mWV*m*^ 
m - tm 
<- exon 2-intron 
<- intron 
<- pre-mRNA 
^mRNA 
<- exon 1 
1 2 3 4 5 6 7 
Qs o H - K - ON i—' 0 0 
p o. ~ - ^ g £ % splicing 
K> -i^  -told increase N> N> 
4^ O 
Figure 26. U6 reconstitution requires addition of a blocking oligonucleotide. Splicing in 
mock depleted (lane 1) or U6-depleted (lanes 2-6) splicing extract in the presence of 
the indicated concentrations of IVT U6. 1 .25|JM blocking oligonucleotide (SDR588) 
was added to reactions 5 and 6 prior to addition of IVT U6. Lane 7 is a positive 
splicing control. Splicing efficiency and fold increase in splicing upon reconstitution 
are shown below the gel. 
To improve reconstitution of splicing in U6-depleted extract, I investigated lower 
concentrations of targeting oligonucleotide and higher concentrations of blocking 
oligonucleotide and IVT U6. Targeting oligonucleotide concentrations below 0.3|aM resulted 
in lower efficiencies of U6 degradation (Figure 27b) and splicing inhibition (Figure 27a), and 
therefore produced a smaller increase in splicing upon reconstitution. However, increasing 
the concentration of both the blocking oligonucleotide (Figure 27a, lane 6) and IVT U6 
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(Figure 27a, lane 8) improved splicing reconstitution from 4.7% to 5.5% and 5.9%, 
respectively, though still not to the level reported by Fabrizio et al. (1989). Further increases 
in blocking oligonucleotide concentration did not improve splicing reconstitution (data not 
shown). 
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Figure 27. 0.3 uJVI oligonucleotide allows maximal U6 degradation and reconstitution. a) 
Inhibition of splicing by incubation of extract with 0.05 to 0.3 uM SDR419 and 
reconstitution of splicing by addition of 100 or 200 nM IVT U6. Blocking oligo was 
added prior to IVT U6 at 1.25uM (lanes 5, 7, and 8) or 2.5|j.M (lane 6). Lanes 9 and 
10 are positive and negative splicing controls, respectively. Splicing efficiency of 
each reaction and fold increase in splicing upon reconstitution are shown below the 
gel. b) Degradation of U6 by incubation of extract with the indicated concentrations 
of SDR419. Degradation efficiency is shown below the gel. 
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As efficiency of splicing reconstitution was better with 200(iM IVT U6 than 100|JM 
(Figure27a, lanes 7 and 8), I examined the effect of further increases in IVT U6 
concentration on reconstitution efficiency. Figure 28a shows that reconstitution by 400nM 
IVT U6 was approximately equal to that by 500nM but better than that by 300nM or 600nM 
(data not shown). Splicing reconstitution was further improved by performing a five minute 
incubation at 23°C between addition of the blocking oligonucleotide and addition of IVT U6 
(Figure 28a, lanes 7 and 8). In summary, maximum reconstitution of splicing in U6-depleted 
extract was achieved by adding 2.5(^ M blocking oligonucleotide, incubating the reaction for 
five minutes at 23°C, then adding 400nM IVT U6. These conditions yielded a splicing 
efficiency of 14.9%, an approximately 10-fold increase over the U6-depleted extract. 
Splicing reconstitution efficiency in U6-depleted extract also varied substantially 
depending on the extract preparation used (Figure 28a, lanes 5-7). This variation was not due 
to differences in U6 degradation, since, as shown in Figure 28b, U6 degradation was nearly 
equal in the three extracts, resulting in similarly close levels of splicing inhibition (Figure 
28a, lanes 2-4). Differences in the concentrations of U6-specific proteins or endogenous 
nucleases may have contributed to the observed extract-specific reconstitution efficiencies. 
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Figure 28. U6 Reconstitution efficiency is extract dependent, a) Inhibition of splicing in 
three different extracts (11, 1, and 2) and reconstitution of splicing by addition of 300 
to 500nM IVT U6. Reaction 8 had a five minute incubation at 23°C between addition 
of 2.5|iM blocking oligonucleotide and IVT U6. Lanes 11 and 12 are positive and 
negative splicing controls, respectively. Splicing efficiency and fold increase in 
splicing upon reconstitution are shown below the gel. b) Northern blot showing 
degradation of endogenous U6 in each of the extracts. 
4.2.2 Generation of U4/U6-Depleted Splicing Extract 
Investigation of the kissing-loop hypothesis requires generation of extract depleted of 
both U4 and U6. While U4 degradation must be performed under conditions of active 
splicing (Figures 5 and 6), U6 degradation is greatly inhibited by such conditions (Figure 
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29a). This suggests that, upon incorporation of U6 into the active spliceosome, the targeted 
region of U6, nucleotides 28-54, becomes protected from binding by the targeting 
oligonucleotide and subsequent degradation by RNase H. Given that the 3' portion of the 
targeted sequence contains the ACAGAGA sequence that binds to the 5' splice site in the 
active spliceosome, it is likely that this competition for binding of the target sequence, as 
well as steric hindrance from surrounding spliceosomal components, inhibited binding of the 
targeting oligonucleotide and degradation by RNase H. I successfully generated U4/U6 
depleted extract by sequential degradation of U4 (under splicing conditions) followed by U6 
(under non-splicing conditions due to U4 degradation) (Figure29b and c). Similarly, it should 
be possible to follow degradation of U6 under non-splicing conditions by degradation of U4, 
since the prior degradation of U6 should have released U4 into the free snRNP species which 
is accessible to its targeting oligonucleotide. These two approaches will be compared in 
future experiments examining the efficiencies of splicing inhibition and reconstitution in 
U4/U6-depleted extract. 
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Figure 29. U6 degradation efficiency is decreased under conditions of active splicing, a) 
Northern blot showing degradation of U6 under conditions of active splicing, b) and 
c) Northern blot showing degradation of b) U6 and c) U4 either alone (lane 2) or by 
sequential degradation of U4 followed by U6 (lane 3). Degradation efficiency is 
shown below the gels. 
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CHAPTER 5 
Future Directions 
Successful development of a U4 in vitro reconstitution system opens to door to a wide 
array of experiments exploring the effects of specific mutations in U4 on its ability to interact 
with other spliceosomal components and to participate in the splicing reaction. Such 
experiments will play a key role in defining the structure and function of the U4 snRNP, thus 
contributing to our overall understanding of the mechanism by which pre-mRNA splicing is 
accomplished. 
5.1 Identification of U4 snRNP Proteins and Their snRNA Binding Sites 
As discussed above in Section 3.2.2.2, our knowledge of the identities of the proteins 
associated with U4 snRNA, the RNA sequences to which they bind, and their functions in 
spliceosome assembly and splicing is rather limited. While the list of putative U4-associated 
proteins includes Snul3, Prp3, Prp4, and Prp31, direct binding to U4 has been demonstrated 
by crystal structure determination or UV cross-linking for only Snul3 and Prp31 (Nottrott et 
al. 1999, Vidovic et al. 2000, Nottrott et al. 2002). Furthermore, these analyses were 
performed using only fragments of the 5' portion of U4 snRNA, so that any interactions of 
these proteins with 3' regions of the molecule would have gone undetected. 
The U4 in vitro reconstitution assay presented here provides a useful technique for 
further investigation of the protein complement of the U4 snRNP. By reconstituting U4-
depleted extract with 32P-labeled IVT U4, assembly of the U4 snRNP can be visualized using 
non-denaturing gel electrophoresis. We have found that depletion of U6 prevents assembly of 
the reconstituted U4 snRNPs into di- or tri-snRNPs, resulting in a clear accumulation of the 
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free U4 snRNP (data not shown). By using yeast strains in which individual potential U4-
associated proteins have been labeled with a TAP tag, this reconstitution assay could then be 
used to investigate the protein components of the U4 snRNP through antibody supershift 
analysis. Such an experiment may even shed light on the temporal organization of snRNP 
assembly. Initial investigation of U4 snRNP assembly has suggested that this process occurs 
in a stepwise manner, as indicated by the appearance of multiple lower bands below the fully 
assembled U4 snRNP (data not shown). Identification of the proteins present in each band 
through supershift analysis could therefore contribute to our understanding of the relative 
timing of the interactions involved in U4 snRNP assembly. 
To further elucidate the interactions involved in U4 snRNP assembly, antibody 
supershift analysis could be performed in extract reconstituted with mutant U4 snRNAs. 
Individual deletion or point mutations could thereby be linked to disruption of the association 
of specific proteins, providing insight into the regions of the snRNA that are required for the 
binding of these proteins, either directly or through another splicing factor. 
Supershift analysis of a U4 3' stem-loop deletion mutant would be particularly 
interesting, since, by identifying any protein factors requiring this region for association with 
U4, such an experiment may clarify why this domain is essential for di-snRNP formation in 
yeast. As a mutational analysis of yeast U4 identified deletion of nucleotides 131-133 as the 
only mutation in the 3' stem-loop that affected growth (Hu et al. 1995), performing supershift 
analysis with this mutant may assist in pinpointing the sequence in the 3' stem-loop required 
for any protein associations. 
Another useful technique for identifying U4 snRNA interaction partners that is made 
possible by the availability of a U4 in vitro reconstitution assay is formation of specific 
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cross-links between U4 snRNA and other spliceosomal components. By reconstituting with 
4-thiouridine-labeled U4, this procedure would allow mapping of the interactions of 
individual U4 nucleotides. Placement of a 4-thiouridine residue near nucleotides 131-133 
may be particularly informative for determining the essential function of the 3' stem-loop. 
5.2 Analysis of Formation of the U4/U6 di-snRNP 
Development of a U4 in vitro reconstitution assay also facilitates investigation of 
the mechanism of U4/U6 di-snRNP formation. As discussed in Section 1.6.1, it has been 
proposed that these snRNAs first interact through complementary nucleotides located in loop 
structures at the 5' end of U4 and the 3' end of U6 (Figure 3b), initiating formation of stems I 
and II (Karaduman et al. 2006; Ollenberger and Rader, unpublished results). To test this so-
called kissing-loop model of U4/U6 interaction, site-directed mutagenesis could be used to 
generate specific U4 and U6 mutants. Reconstitution of U4-depleted extract with U4 snRNA 
mutated at nucleotides 7-10, the 5' loop residues, would allow examination of the prediction 
that disruption of the putative loop-loop interaction would block U4/U6 base-pairing and 
splicing. Using extract that has been co-depleted of U4 and U6 using the protocol described 
in Section 4.2.2, U4/U6 base-pairing and splicing activity could then be analyzed following 
reconstitution with the U4 mutant and a U6 mutant containing compensatory base changes in 
its putative kissing-loop sequence. If the kissing-loop model is correct, and if the mutated 
residues do not play a role beyond the U4/U6 interaction, di-snRNP formation and splicing 
activity would be restored. Restoration of the U4/U6 interaction but continued blockage of 
splicing would still support the kissing-loop model, but would also indicate that the mutated 
residues play a role beyond initiation of di-snRNP formation. 
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A second aspect of U4/U6 di-snRNP formation that may be illuminated using the U4 
in vitro reconstitution assay concerns the function of the splicing factor Prp24. As previously 
discussed, this protein is thought to catalyze U4/U6 annealing, but it is not clear if its role is 
limited to di-snRNP formation, or whether it also performs an additional function later in 
spliceosome assembly by promoting the unwinding of the U4/U6 duplex required for 
formation of the active spliceosome (Ghetti et al. 1995, Raghunathan and Guthrie 1998, 
Vidaver et al. 1999). If the function of Prp24 is indeed limited to promotion of U4/U6 
annealing by bringing these snRNAs into close proximity, then association of the snRNAs 
through an alternative means would be expected to eliminate the requirement for Prp24. One 
possible approach to investigate this question is to fuse the U4 and U6 snRNAs and look at 
weather this hybrid molecule is able to reconstitute splicing in U4/U6-depleted extract. If the 
fused snRNAs are functional, then examination of splicing reconstitution in extract 
immunodepleted of Prp24 would reveal whether this mutation makes Prp24 redundant. If 
Prp24 is dispensable in this system, then only an early, duplex-forming role for Prp24 would 
be supported, whereas lack of splicing reconstitution by the fused snRNAs in the absence of 
Prp24 would indicate that either the snRNAs are unable to base-pair without Prp24, or that 
the U4/U6 duplex is formed, but Prp24 is required for progression to the active spliceosome. 
Together, these experiments would help define the complex and dynamic network of 
interactions involved in pre-mRNA splicing. 
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